Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Medtronic
Johnson and Johnson
Farmers Insurance
UBS
Queensland Health
Cerilliant
Express Scripts
Cantor Fitzgerald
Moodys

Generated: February 24, 2018

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

When do Hydrochlorothiazide patents expire, and when can generic versions of Hydrochlorothiazide launch?

Hydrochlorothiazide is a drug marketed by Alembic Pharms Ltd, Apotex, Aurobindo Pharma, Hikma Intl Pharms, Ipca Labs Ltd, Ivax Sub Teva Pharms, Jubilant Cadista, Lannett Holdings Inc, Mylan, Prinston Inc, Sun Pharm Inds Inc, Unichem, Morton Grove, Roxane, Abc Holding, Accord Hlthcare, Actavis Elizabeth, Alra, Ascot, Aurolife Pharma Llc, Barr, Chartwell Rx, Dava Pharms Inc, Elkins Sinn, Heather, Heritage Pharms Inc, Impax Labs, Inwood Labs, Lannett, Leading Pharma Llc, Mast Mm, Mylan Pharms Inc, Pvt Form, Sciegen Pharms Inc, Solvay, Sun Pharm Industries, Superpharm, Teva, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, Watson Labs Teva, West Ward, Whiteworth Town Plsn, Yaopharma Co Ltd, and Pharmeral. and is included in one hundred and nine NDAs.

The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. There are seven tentative approvals for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Drug patent expirations by year for HYDROCHLOROTHIAZIDE
Pharmacology for HYDROCHLOROTHIAZIDE
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 040412-002 Mar 29, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 085232-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Heritage Pharms Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 085182-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Barr HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 084771-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Superpharm HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 088827-001 Dec 28, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Yaopharma Co Ltd HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 087565-001 Mar 9, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inwood Labs HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 084776-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Whiteworth Town Plsn HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 083809-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 084324-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 083607-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Chinese Patent Office
Covington
Queensland Health
Johnson and Johnson
Fuji
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot